Related Experiment Videos
Node-negative breast cancer: tamoxifen and chemosuppression
1Department of Human Oncology and Pharmacology, University of Wisconsin Clinical, Madison 53792.
Journal of the National Cancer Institute
|June 20, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol.
British journal of pharmacology·2014
Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death.
British journal of cancer·2014
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clinical pharmacology and therapeutics·2013
Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells.
British journal of pharmacology·2013
Laboratory models of breast and endometrial cancer to develop strategies for antiestrogen therapy.
Breast cancer (Tokyo, Japan)·2008
Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.
Journal of the National Cancer Institute·2026
Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.
Journal of the National Cancer Institute·2026
Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.
Journal of the National Cancer Institute·2026
Examining the role of extrachromosomal DNA in lung cancer.
Journal of the National Cancer Institute·2026
Differential impact of lymphocytes on radiation response in autochthonous vs transplant murine sarcomas.
Journal of the National Cancer Institute·2026
Nitrate and nitrite intake and risk of colorectal cancer: a population-based cohort study.
Journal of the National Cancer Institute·2026
Total neoadjuvant therapy for rectal cancer: where are we now, where do we go?
Clinical and translational radiation oncology·2026